Quest Diagnostics Earnings Beat After March Rebound In Demand From Slump Early In The Quarter -- MarketWatch

Dow Jones

2025/04/22

Quest Diagnostics Inc.'s stock fell 3.6% early Tuesday, after the company posted better-than-expected first-quarter earnings and backed its guidance, but said the early part of the quarter was slow.

Secaucus, N.J.-based Quest $(DGX)$ had adjusted per-share earnings of $2.21, up 8.3% from a year ago and ahead of the $2.15 FactSet consensus. Revenue rose 12.1% to $2.652 billion, also ahead of the $2.630 billion FactSet consensus.

Chief Executive Jim Davis said growth rebounded in March after a weather-related slump early in the quarter. "Our growth was due to contributions from acquisitions and large enterprise accounts, demand for our advanced diagnostics portfolio, and expanded health plan access," he said in prepared remarks.

The company backed its revenue guidance for 2025 of $10.7 billion to $10.85 billion. It raised its EPS guidance to $8.62 to $8.87 from $8.34 to $8.59 previously, but stuck with adjusted EPs guidance of $9.55 to $9.80.

(This is a breaking news story. Check back for updates)

-Ciara Linnane

For more from MarketWatch: http://www.marketwatch.com/newsviewer

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

April 22, 2025 07:01 ET (11:01 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2529743433"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2529743433\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2529743433?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-22 19:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2529743433","market":"nz","top_or_hot":-1,"title":"Quest Diagnostics Earnings Beat After March Rebound In Demand From Slump Early In The Quarter -- MarketWatch","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     Quest Diagnostics Inc.'s stock fell 3.6% early Tuesday, after the company  posted better-than-expected first-quarter earnings and backed its guidance, but said the early part of the quarter was slow. \n</p>\n<p>\n     Secaucus, N.J.-based Quest <a href=\"https://laohu8.com/S/DGX\">$(DGX)$</a> had adjusted per-share earnings of $2.21, up 8.3% from a year ago and ahead of the $2.15 FactSet consensus. Revenue rose 12.1% to $2.652 billion, also ahead of the $2.630 billion FactSet consensus. \n</p>\n<p>\n     Chief Executive Jim Davis said growth rebounded in March after a weather-related slump early in the quarter. \"Our growth was due to contributions from acquisitions and large enterprise accounts, demand for our advanced diagnostics portfolio, and expanded health plan access,\" he said in prepared remarks. \n</p>\n<p>\n     The company backed its revenue guidance for 2025 of $10.7 billion to $10.85 billion. It raised its EPS guidance to $8.62 to $8.87 from $8.34 to $8.59 previously, but stuck with adjusted EPs guidance of $9.55 to $9.80. \n</p>\n<p>\n     (This is a breaking news story. Check back for updates) \n</p>\n<p>\n     -Ciara Linnane \n</p>\n<p>\n  For more from MarketWatch: http://www.marketwatch.com/newsviewer \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 22, 2025 07:01 ET (11:01 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Quest Diagnostics Earnings Beat After March Rebound In Demand From Slump Early In The Quarter -- MarketWatch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuest Diagnostics Earnings Beat After March Rebound In Demand From Slump Early In The Quarter -- MarketWatch\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-04-22 19:01</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     Quest Diagnostics Inc.'s stock fell 3.6% early Tuesday, after the company  posted better-than-expected first-quarter earnings and backed its guidance, but said the early part of the quarter was slow. \n</p>\n<p>\n     Secaucus, N.J.-based Quest <a href=\"https://laohu8.com/S/DGX\">$(DGX)$</a> had adjusted per-share earnings of $2.21, up 8.3% from a year ago and ahead of the $2.15 FactSet consensus. Revenue rose 12.1% to $2.652 billion, also ahead of the $2.630 billion FactSet consensus. \n</p>\n<p>\n     Chief Executive Jim Davis said growth rebounded in March after a weather-related slump early in the quarter. \"Our growth was due to contributions from acquisitions and large enterprise accounts, demand for our advanced diagnostics portfolio, and expanded health plan access,\" he said in prepared remarks. \n</p>\n<p>\n     The company backed its revenue guidance for 2025 of $10.7 billion to $10.85 billion. It raised its EPS guidance to $8.62 to $8.87 from $8.34 to $8.59 previously, but stuck with adjusted EPs guidance of $9.55 to $9.80. \n</p>\n<p>\n     (This is a breaking news story. Check back for updates) \n</p>\n<p>\n     -Ciara Linnane \n</p>\n<p>\n  For more from MarketWatch: http://www.marketwatch.com/newsviewer \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 22, 2025 07:01 ET (11:01 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DGX","symbol_name":"奎斯特诊疗","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2529743433","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2529743433","pubTimestamp":1745319660,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Quest Diagnostics Inc.'s stock fell 3.6% early Tuesday, after the company  posted better-than-expected first-quarter earnings and backed its guidance, but said the early part of the quarter was slow.Secaucus, N.J.-based Quest  had adjusted per-share earnings of $2.21, up 8.3% from a year ago and ahead of the $2.15 FactSet consensus. Revenue rose 12.1% to $2.652 billion, also ahead of the $2.630 billion FactSet consensus.Chief Executive Jim Davis said growth rebounded in March after a weather-related slump early in the quarter. \"Our growth was due to contributions from acquisitions and large enterprise accounts, demand for our advanced diagnostics portfolio, and expanded health plan access,\" he said in prepared remarks.The company backed its revenue guidance for 2025 of $10.7 billion to $10.85 billion. It raised its EPS guidance to $8.62 to $8.87 from $8.34 to $8.59 previously, but stuck with adjusted EPs guidance of $9.55 to $9.80.This content was created by MarketWatch, which is opera","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"DGX":"奎斯特诊疗"},"translate_title":"Quest Diagnostics的盈利在3月份需求从季度初的低迷中反弹后超出预期——MarketWatch","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DGX":1},"content_text":"Quest Diagnostics Inc.'s stock fell 3.6% early Tuesday, after the company  posted better-than-expected first-quarter earnings and backed its guidance, but said the early part of the quarter was slow. \n\n\n     Secaucus, N.J.-based Quest $(DGX)$ had adjusted per-share earnings of $2.21, up 8.3% from a year ago and ahead of the $2.15 FactSet consensus. Revenue rose 12.1% to $2.652 billion, also ahead of the $2.630 billion FactSet consensus. \n\n\n     Chief Executive Jim Davis said growth rebounded in March after a weather-related slump early in the quarter. \"Our growth was due to contributions from acquisitions and large enterprise accounts, demand for our advanced diagnostics portfolio, and expanded health plan access,\" he said in prepared remarks. \n\n\n     The company backed its revenue guidance for 2025 of $10.7 billion to $10.85 billion. It raised its EPS guidance to $8.62 to $8.87 from $8.34 to $8.59 previously, but stuck with adjusted EPs guidance of $9.55 to $9.80. \n\n\n     (This is a breaking news story. Check back for updates) \n\n\n     -Ciara Linnane \n\n\n  For more from MarketWatch: http://www.marketwatch.com/newsviewer \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 22, 2025 07:01 ET (11:01 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}